SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32%
SBC Medical Group (NASDAQ:SBC) said its growth re-accelerated in the second quarter of 2026 as the company completed structural reforms undertaken in 2025, expanded its clinic network and increased management-services revenue. The medical services organization, which provides centralized management support to clinics across aesthetic medicine and other healthcare categories, reported second-quarter revenue of $49 million, […]
19 Aug 18:03 · The Markets Daily